688222 成都先导
已收盘 05-08 15:00:01
资讯
新帖
简况
【机构调研记录】德邦基金调研成都先导、盛弘股份
证券之星 · 05-08 08:06
【机构调研记录】德邦基金调研成都先导、盛弘股份
成都先导（688222）披露2025年年度股东会会议资料，5月7日股价上涨0.14%
证券之星 · 05-07 17:40
成都先导（688222）披露2025年年度股东会会议资料，5月7日股价上涨0.14%
每周股票复盘：成都先导（688222）Q1收入增50.4%
证券之星 · 05-02
每周股票复盘：成都先导（688222）Q1收入增50.4%
成都先导（688222）2026年一季报简析：营收净利润同比双双增长，公司应收账款体量较大
证券之星 · 04-30
成都先导（688222）2026年一季报简析：营收净利润同比双双增长，公司应收账款体量较大
成都先导(688222)3月31日股东户数2.58万户，较上期增加25.56%
证券之星 · 04-29
成都先导(688222)3月31日股东户数2.58万户，较上期增加25.56%
图解成都先导年报：第四季度单季净利润同比下降21.68%
证券之星 · 04-29
图解成都先导年报：第四季度单季净利润同比下降21.68%
每周股票复盘：成都先导（688222）深圳钧天减持期满未减持
证券之星 · 04-26
每周股票复盘：成都先导（688222）深圳钧天减持期满未减持
4月22日成都先导涨5.44%，中证2000ETF华泰柏瑞基金重仓该股
证券之星 · 04-22
4月22日成都先导涨5.44%，中证2000ETF华泰柏瑞基金重仓该股
成都先导（688222）披露股东减持结果公告，4月21日股价下跌2.9%
证券之星 · 04-21
成都先导（688222）披露股东减持结果公告，4月21日股价下跌2.9%
4月3日成都先导跌5.97%，中证2000ETF华泰柏瑞基金重仓该股
证券之星 · 04-03
4月3日成都先导跌5.97%，中证2000ETF华泰柏瑞基金重仓该股
3月23日成都先导跌6.78%，华泰柏瑞中证2000ETF基金重仓该股
证券之星 · 03-23
3月23日成都先导跌6.78%，华泰柏瑞中证2000ETF基金重仓该股
成都先导（688222）披露2026年第一次临时股东会决议公告，3月2日股价下跌3.52%
证券之星 · 03-02
成都先导（688222）披露2026年第一次临时股东会决议公告，3月2日股价下跌3.52%
每周股票复盘：成都先导（688222）2025年净利增122.01%
证券之星 · 03-01
每周股票复盘：成都先导（688222）2025年净利增122.01%
成都先导（688222）披露2025年度业绩快报公告，2月27日股价上涨0.17%
证券之星 · 02-27
成都先导（688222）披露2025年度业绩快报公告，2月27日股价上涨0.17%
成都先导（688222）披露拟以2400万元认购先衍生物新增注册资本，2月26日股价下跌1.25%
证券之星 · 02-26
成都先导（688222）披露拟以2400万元认购先衍生物新增注册资本，2月26日股价下跌1.25%
每周股票复盘：成都先导（688222）股东增持94.56万股，业绩预增超102%
证券之星 · 02-01
每周股票复盘：成都先导（688222）股东增持94.56万股，业绩预增超102%
成都先导与康哲药业达成合作 DEL及HAILO平台赋能多靶点创新药开发
人民财讯 · 01-30
成都先导与康哲药业达成合作 DEL及HAILO平台赋能多靶点创新药开发
成都先导（688222）披露2025年年度业绩预增公告，1月27日股价上涨1.55%
证券之星 · 01-27
成都先导（688222）披露2025年年度业绩预增公告，1月27日股价上涨1.55%
成都先导(688222.SH)发预增，预计2025年归母净利润1.04亿元到1.27亿元，同比增加102.50%到147.29%
智通财经 · 01-27
成都先导(688222.SH)发预增，预计2025年归母净利润1.04亿元到1.27亿元，同比增加102.50%到147.29%
1月19日成都先导跌6.82%，华泰柏瑞中证2000ETF基金重仓该股
证券之星 · 01-19
1月19日成都先导跌6.82%，华泰柏瑞中证2000ETF基金重仓该股
加载更多
公司概况
公司名称：
成都先导药物开发股份有限公司
所属行业：
研究和试验发展
上市日期：
2020-04-16
主营业务：
成都先导药物开发股份有限公司的主营业务是药物研发并提供技术咨询、技术转让和技术服务等。公司的主要产品是新药研发服务、新药在研项目权益转让。
发行价格：
20.52
{"stockData":{"symbol":"688222","market":"SH","secType":"STK","nameCN":"成都先导","latestPrice":27,"timestamp":1778223601000,"preClose":29.04,"halted":0,"volume":32583116,"delay":0,"changeRate":-0.0702,"floatShares":401000000,"shares":401000000,"eps":0.3063,"marketStatus":"已收盘","change":-2.04,"latestTime":"05-08 15:00:01","open":27.4,"high":27.5,"low":26.5,"amount":880000000,"amplitude":0.0344,"askPrice":27,"askSize":156,"bidPrice":26.99,"bidSize":277,"shortable":0,"etf":0,"ttmEps":0.3063,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778463000000},"marketStatusCode":5,"adr":0,"adjPreClose":29.04,"symbolType":"stock_kcb","openAndCloseTimeList":[[1778203800000,1778211000000],[1778216400000,1778223600000]],"highLimit":31.94,"lowLimit":26.14,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":400680000,"isCdr":false,"pbRate":7.03,"roa":"--","peRate":88.148874,"roe":"2.73%","epsLYR":0.27,"committee":0.283843,"marketValue":10818000000,"turnoverRate":0.0813,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-05-11。","afterMarket":{"amount":21600,"volume":800,"close":27,"buyVolume":400,"sellVolume":0,"time":1778225637558,"indexStatus":"已收盘 05-08 15:30:00","preClose":29.04},"floatMarketCap":10818000000},"requestUrl":"/m/hq/s/688222","defaultTab":"news","newsList":[{"id":"2633910607","title":"【机构调研记录】德邦基金调研成都先导、盛弘股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2633910607","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633910607?lang=zh_cn&edition=full","pubTime":"2026-05-08 08:06","pubTimestamp":1778198794,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及5月7日披露的机构调研信息，德邦基金近期对2家上市公司进行了调研，相关名单如下：1）成都先导 调研纪要：成都先导持续推进DEL+AI/ML在新药发现中的应用，构建HILO平台实现“设计-合成-测试-分析”闭环。2）盛弘股份 调研纪要：公司2026年一季度营收约7.44亿元，同比增长23.13%；归母净利润8518.42万元，同比增长16.86%。IDC部门已于2025年下半年成立，相关产品按计划研发推广。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800006527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0224","BK0216","BK0156","688222","300693"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633141851","title":"成都先导（688222）披露2025年年度股东会会议资料，5月7日股价上涨0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633141851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633141851?lang=zh_cn&edition=full","pubTime":"2026-05-07 17:40","pubTimestamp":1778146844,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，成都先导报收于29.04元，较前一交易日上涨0.14%，最新总市值为116.36亿元。该股当日开盘28.99元，最高29.67元，最低28.65元，成交额达5.94亿元，换手率为5.11%。近日，成都先导药物开发股份有限公司发布《2025年年度股东会会议资料》。公告显示，公司拟召开2025年年度股东大会，会议定于2026年5月29日以现场与网络投票相结合方式举行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700029379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632649018","title":"每周股票复盘：成都先导（688222）Q1收入增50.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632649018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632649018?lang=zh_cn&edition=full","pubTime":"2026-05-02 01:59","pubTimestamp":1777658348,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，成都先导报收于28.61元，较上周的26.25元上涨8.99%。本周，成都先导4月30日盘中最高价报29.0元。本周关注点来自业绩披露要点：成都先导2026年一季报主营收入1.61亿元，同比上升50.4%。股本股东变化截至2026年3月31日，成都先导股东户数为2.58万户，较2025年12月31日增加5252户，增幅达25.56%。业绩披露要点成都先导2026年一季报显示，公司实现营业收入1.61亿元，同比增长50.40%；归母净利润4150.02万元，同比增长46.72%；扣非净利润3963.36万元，同比增长126.40%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200000316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631257864","title":"成都先导（688222）2026年一季报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2631257864","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631257864?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:53","pubTimestamp":1777503224,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期成都先导发布2026年一季报。截至本报告期末，公司营业总收入1.61亿元，同比上升50.4%，归母净利润4150.02万元，同比上升46.72%。本报告期成都先导公司应收账款体量较大，当期应收账款占最新年报归母净利润比达79.86%。去年的净利率为20.94%，算上全部成本后，公司产品或服务的附加值高。持有成都先导最多的基金为中证2000ETF华泰柏瑞，目前规模为35.6亿元，最新净值1.5478，较上一交易日上涨1.52%，近一年上涨48.35%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000023807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631510596","title":"成都先导(688222)3月31日股东户数2.58万户，较上期增加25.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631510596","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631510596?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:42","pubTimestamp":1777455779,"startTime":"0","endTime":"0","summary":"证券之星消息，近日成都先导披露，截至2026年3月31日公司股东户数为2.58万户，较12月31日增加5252.0户，增幅为25.56%。在医疗服务行业个股中，成都先导股东户数低于行业平均水平，截至3月31日，医疗服务行业平均股东户数为4.91万户。从股价来看，2025年12月31日至2026年3月31日，成都先导区间涨幅为9.94%，在此期间股东户数增加5252.0户，增幅为25.56%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900055388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631758280","title":"图解成都先导年报：第四季度单季净利润同比下降21.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631758280","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631758280?lang=zh_cn&edition=full","pubTime":"2026-04-29 01:08","pubTimestamp":1777396123,"startTime":"0","endTime":"0","summary":"证券之星消息，成都先导2025年年报显示，当年度公司主营收入5.26亿元，同比上升23.09%；归母净利润1.1亿元，同比上升113.22%；扣非净利润1.13亿元，同比上升96.27%；其中2025年第四季度，公司单季度主营收入1.56亿元，同比上升21.02%；单季度归母净利润1663.33万元，同比下降21.68%；单季度扣非净利润2265.9万元，同比下降43.53%；负债率22.88%，投资收益346.22万元，财务费用-523.34万元，毛利率54.22%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900003257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630980451","title":"每周股票复盘：成都先导（688222）深圳钧天减持期满未减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2630980451","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630980451?lang=zh_cn&edition=full","pubTime":"2026-04-26 03:31","pubTimestamp":1777145469,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，成都先导报收于26.25元，较上周的26.91元下跌2.45%。本周，成都先导4月23日盘中最高价报27.76元。2026年1月17日，公司披露深圳钧天拟在2026年1月22日至2026年4月21日期间通过集中竞价和大宗交易方式减持不超过10,067,751股，占总股本约2.51%。截至减持计划期满，深圳钧天未实施减持，仍持有公司股份10,067,751股，占总股本2.51%。本次减持未违反相关法规及承诺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629015197","title":"4月22日成都先导涨5.44%，中证2000ETF华泰柏瑞基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629015197","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629015197?lang=zh_cn&edition=full","pubTime":"2026-04-22 16:28","pubTimestamp":1776846510,"startTime":"0","endTime":"0","summary":"证券之星消息，4月22日成都先导涨5.44%，收盘报27.5元，换手率5.29%，成交量21.2万手，成交额5.7亿元。重仓成都先导的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家；过去90天内机构目标均价为27.2。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为华泰柏瑞基金的中证2000ETF华泰柏瑞。中证2000ETF华泰柏瑞目前规模为35.6亿元，最新净值1.5418，较上一交易日下跌0.19%，近一年上涨48.16%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200037706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222","BK0216","563300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629037004","title":"成都先导（688222）披露股东减持结果公告，4月21日股价下跌2.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629037004","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629037004?lang=zh_cn&edition=full","pubTime":"2026-04-21 22:04","pubTimestamp":1776780268,"startTime":"0","endTime":"0","summary":"截至2026年4月21日收盘，成都先导报收于26.08元，较前一交易日下跌2.9%，最新总市值为104.5亿元。该股当日开盘26.65元，最高26.88元，最低25.72元，成交额达3.97亿元，换手率为3.8%。2026年1月17日，公司披露深圳钧天拟在2026年1月22日至2026年4月21日期间通过集中竞价和大宗交易方式减持不超过10,067,751股，占总股本约2.51%。截至减持计划期满，深圳钧天未实施减持，仍持有公司股份10,067,751股，占总股本2.51%。本次减持未违反相关法规及承诺。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100052630.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624655188","title":"4月3日成都先导跌5.97%，中证2000ETF华泰柏瑞基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624655188","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624655188?lang=zh_cn&edition=full","pubTime":"2026-04-03 16:12","pubTimestamp":1775203932,"startTime":"0","endTime":"0","summary":"证券之星消息，4月3日成都先导跌5.97%，收盘报26.15元，换手率6.81%，成交量27.27万手，成交额7.24亿元。重仓成都先导的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家；过去90天内机构目标均价为27.2。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华泰柏瑞基金的中证2000ETF华泰柏瑞。中证2000ETF华泰柏瑞目前规模为26.75亿元，最新净值1.419，较上一交易日下跌1.64%，近一年上涨29.67%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300031145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","563300","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621077636","title":"3月23日成都先导跌6.78%，华泰柏瑞中证2000ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621077636","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621077636?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:36","pubTimestamp":1774254994,"startTime":"0","endTime":"0","summary":"证券之星消息，3月23日成都先导跌6.78%，收盘报22.7元，换手率3.22%，成交量12.92万手，成交额3.02亿元。重仓成都先导的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家；过去90天内机构目标均价为27.2。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华泰柏瑞基金的华泰柏瑞中证2000ETF。华泰柏瑞中证2000ETF目前规模为26.75亿元，最新净值1.4307，较上一交易日下跌2.21%，近一年上涨23.63%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222","BK0216","562660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616869356","title":"成都先导（688222）披露2026年第一次临时股东会决议公告，3月2日股价下跌3.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616869356","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616869356?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:53","pubTimestamp":1772463192,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，成都先导报收于28.25元，较前一交易日下跌3.52%，最新总市值为113.19亿元。成都先导药物开发股份有限公司于2026年3月2日召开2026年第一次临时股东会，会议由董事长JIN LI（李进）主持，采用现场与网络投票结合方式召开，出席会议股东及代理人共120人，代表有表决权股份135,116,115股，占公司总表决权股份的33.8263%。关联股东未出席本次会议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200040175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616843712","title":"每周股票复盘：成都先导（688222）2025年净利增122.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616843712","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616843712?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:20","pubTimestamp":1772302822,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，成都先导报收于29.28元，较上周的29.45元下跌0.58%。本周，成都先导2月24日盘中最高价报30.36元。本周关注点来自业绩披露要点：成都先导2025年归属净利润同比增长122.01%。来自公司公告汇总：成都先导拟出资2,400万元参与先衍生物增资。成都先导发布2025年度业绩快报，营业总收入52,557.18万元，同比增长23.09%；营业利润12,567.42万元，同比增长99.58%；归属于母公司所有者的净利润11,401.66万元，同比增长122.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614017852","title":"成都先导（688222）披露2025年度业绩快报公告，2月27日股价上涨0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614017852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614017852?lang=zh_cn&edition=full","pubTime":"2026-02-27 22:55","pubTimestamp":1772204113,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，成都先导报收于29.28元，较前一交易日上涨0.17%，最新总市值为117.32亿元。该股当日开盘29.0元，最高29.53元，最低28.9元，成交额达1.84亿元，换手率为1.56%。近日，成都先导发布2025年度业绩快报，营业总收入52,557.18万元，同比增长23.09%；营业利润12,567.42万元，同比增长99.58%；归属于母公司所有者的净利润11,401.66万元，同比增长122.01%。报告期末总资产195,592.58万元，同比增长11.35%；归属于母公司的所有者权益149,214.79万元，同比增长7.11%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700042845.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614028598","title":"成都先导（688222）披露拟以2400万元认购先衍生物新增注册资本，2月26日股价下跌1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614028598","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614028598?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:22","pubTimestamp":1772115739,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘，成都先导报收于29.23元，较前一交易日下跌1.25%，最新总市值为117.12亿元。该股当日开盘29.7元，最高29.74元，最低28.98元，成交额达1.93亿元，换手率为1.65%。近日，成都先导披露《2026年第一次临时股东会会议资料》。公告显示，公司拟以2,400万元认购参股公司先衍生物新增注册资本，交易前持股23.20%，交易后持股比例将根据最终融资金额确定。本次增资按投前估值4.5亿元进行，先衍生物拟融资不超过15,000万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600037231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608072634","title":"每周股票复盘：成都先导（688222）股东增持94.56万股，业绩预增超102%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608072634","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608072634?lang=zh_cn&edition=full","pubTime":"2026-02-01 01:15","pubTimestamp":1769879712,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，成都先导报收于31.11元，较上周的33.6元下跌7.41%。股本股东变化股东增减持1月30日，成都先导公告股东宁波聚智先导生物科技合伙企业于2025年10月13日至2026年1月30日期间累计增持94.56万股，占公司总股本的0.236%，增持金额2,509.84万元。增持后，该股东持股数量为39,596,757股，占总股本9.89%，与一致行动人合计持股比例达30.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688222","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607806521","title":"成都先导与康哲药业达成合作 DEL及HAILO平台赋能多靶点创新药开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2607806521","media":"人民财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607806521?lang=zh_cn&edition=full","pubTime":"2026-01-30 09:13","pubTimestamp":1769735597,"startTime":"0","endTime":"0","summary":"人民财讯1月30日电，据成都先导消息，近日，成都先导与康哲药业控股有限公司（简称“康哲药业”）附属公司签署合作协议，成都先导将为康哲药业针对多个特定靶点的创新药物提供开发服务。成都先导将依托DNA编码化合物库（DEL）技术平台及高通量AI驱动分子优化平台HAILO，为康哲药业提供从靶点验证到临床前候选化合物（PCC）的一站式开发服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601303636273434.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0216","LU2488822045.USD","IE00BYV24P56.USD","IE00BMCWC346.EUR","SG9999015986.USD","SG9999015952.SGD","BK1161","SG9999004220.SGD","00867","06978","BK1574","SG9999015978.USD","BK1593","159992","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","BK1191","IE00BGHQDM52.EUR","688222","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606780275","title":"成都先导（688222）披露2025年年度业绩预增公告，1月27日股价上涨1.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606780275","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606780275?lang=zh_cn&edition=full","pubTime":"2026-01-27 22:23","pubTimestamp":1769523800,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘，成都先导报收于32.86元，较前一交易日上涨1.55%，最新总市值为131.66亿元。该股当日开盘32.62元，最高33.08元，最低31.4元，成交额达5.26亿元，换手率为4.06%。近日，成都先导发布《2025年年度业绩预增公告》。公告显示，公司预计2025年年度归属于母公司所有者的净利润为10,400.00万元到12,700.00万元，同比增长102.50%到147.29%；扣除非经常性损益的净利润为10,600.00万元到12,900.00万元，同比增长84.55%到124.59%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700041899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606892267","title":"成都先导(688222.SH)发预增，预计2025年归母净利润1.04亿元到1.27亿元，同比增加102.50%到147.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606892267","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606892267?lang=zh_cn&edition=full","pubTime":"2026-01-27 20:12","pubTimestamp":1769515966,"startTime":"0","endTime":"0","summary":"智通财经APP讯，成都先导(688222.SH)发布公告，公司预计2025年年度实现归属于母公司所有者的净利润为1.04亿元到1.27亿元，与上年同期相比，将增加5,264.29万元到7,564.29万元，同比增加102.50%到147.29%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"成都先导(688222.SH)发预增，预计2025年归母净利润1.04亿元到1.27亿元，同比增加102.50%到147.29%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604856341","title":"1月19日成都先导跌6.82%，华泰柏瑞中证2000ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2604856341","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604856341?lang=zh_cn&edition=full","pubTime":"2026-01-19 15:36","pubTimestamp":1768808176,"startTime":"0","endTime":"0","summary":"证券之星消息，1月19日成都先导跌6.82%，收盘报32.8元，换手率7.29%，成交量29.22万手，成交额9.76亿元。重仓成都先导的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为华泰柏瑞基金的华泰柏瑞中证2000ETF。华泰柏瑞中证2000ETF目前规模为21.68亿元，最新净值1.474，较上一交易日上涨0.24%，近一年上涨46.26%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900014434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["562660","688222","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778265301153,"stockEarnings":[{"period":"1week","weight":-0.0563},{"period":"1month","weight":-0.0048},{"period":"3month","weight":-0.0952},{"period":"6month","weight":0.1623},{"period":"1year","weight":0.7361},{"period":"ytd","weight":0.1514}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0281},{"period":"6month","weight":0.0456},{"period":"1year","weight":0.247},{"period":"ytd","weight":0.0532}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"成都先导药物开发股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"25798人(较上一季度增加25.56%)","perCapita":"15531股","listingDate":"2020-04-16","address":"四川省成都市武侯区高新区科园南路88号1栋3层","registeredCapital":"40068万元","survey":" 成都先导药物开发股份有限公司的主营业务是药物研发并提供技术咨询、技术转让和技术服务等。公司的主要产品是新药研发服务、新药在研项目权益转让。","listedPrice":20.52},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"成都先导(688222)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供成都先导(688222)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"成都先导,688222,成都先导股票,成都先导股票老虎,成都先导股票老虎国际,成都先导行情,成都先导股票行情,成都先导股价,成都先导股市,成都先导股票价格,成都先导股票交易,成都先导股票购买,成都先导股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"成都先导(688222)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供成都先导(688222)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}